Tobramycin Sulfate Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Jul 17, 2026 · last update Jul 17, 2026
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Jul 17, 2026 Updated Jul 17, 2026 Discontinued Jul 17, 2026 |